Nigović Biljana, Kujundzić Nikola, Sanković Kresimir
Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Eur J Med Chem. 2005 Jan;40(1):51-5. doi: 10.1016/j.ejmech.2004.09.012.
Redox behaviour of the iron(III) complex with the antitumour drug hydroxyurea was studied by cyclic voltammetry. The complex underwent a one-electron reduction, followed by an irreversible chemical reaction (EC mechanism) in which a ligand was released. In addition, it was found that the hydroxyurea gave up an electron to iron(III) in solution. Differential-pulse voltammetry revealed an increase in the concentration of the generated iron(II) species. Electron paramagnetic resonance (EPR) spectroscopy studies of the oxidative degradation of hydroxyurea confirmed formation of the radical species H2N-CO-NHO*. Electrochemical data for iron(III) complexes of hydroxyurea and its structural analogue 3-ethylhydroxyurea, which also exhibits antitumour activity, show the same mechanism involved in the electron transfer. The observed redox properties indicate that hydroxyurea may interfere with electron transfer processes in biological systems after binding to iron-containing ribonucleotide reductase.
通过循环伏安法研究了铁(III)与抗肿瘤药物羟基脲形成的配合物的氧化还原行为。该配合物经历了单电子还原,随后发生不可逆化学反应(EC机制),在此过程中释放出一个配体。此外,发现羟基脲在溶液中向铁(III)给出一个电子。差分脉冲伏安法显示生成的铁(II)物种浓度增加。羟基脲氧化降解的电子顺磁共振(EPR)光谱研究证实形成了自由基物种H2N-CO-NHO*。羟基脲及其同样具有抗肿瘤活性的结构类似物3-乙基羟基脲的铁(III)配合物的电化学数据表明,电子转移涉及相同的机制。观察到的氧化还原性质表明,羟基脲在与含铁的核糖核苷酸还原酶结合后可能会干扰生物系统中的电子转移过程。